FindTrial
Sign In

A clinical trial to Compare effects of purified protein derivative injection with liquid nitrogen spray for treatment of viralwarts

Intralesional injection of purified protein derivative vs cryotherapy in treatment of recalcitrant warts:A Pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/03/005614
Enrollment
70
Registered
2015-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- recalcitrant warts

Interventions

Intervention1: Intralesional injection of purified protein derivative(PPD): largest wart is selected and intralesional injection of 0.1ml of PPD is given .Injections are repeated every 15 days for 6

Sponsors

StJOHN S medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for the procedure 2.males and female patient of age group 18 years and above having multiple common warts( >2) 3.patients having multiple common warts( >2) who have had <50% response to atleast3 sessions of cryotherapy over 2 months period

Exclusion criteria

Exclusion criteria: 1.pregnant females and lactating mothers 2.children under 18 years 3.immunosuppressed individuals 4.Genital and perianal warts 5.Ulcerated or inflammed warts

Design outcomes

Primary

MeasureTime frame
complete disappearance of all the lesion without scarringTimepoint: 3months from starting therapy—

Secondary

MeasureTime frame
look for recurrance of wartsTimepoint: after 3 months after the end of 6 th session—

Countries

India

Contacts

Public ContactDRPremalatha v

St.JOHNS MEDICAL COLLEGE ,BANGALORE

sowmyakaimal@hotmail.com9886023594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026